Shingrix vial kits
Ended Awarded Last action
- Contract number
- SPE2DR26F9KS0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,313
Award facts
- Contract value 100% obligated
- $13,312.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,312.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits, with an ultimate completion date of January 13, 2026. This non-set-aside contract represents a child delivery order under AmerisourceBergen's parent company, Cencora, Inc. The award was made to the Corporate Office division located in Conshohocken, Pennsylvania, where the pharmaceutical products will be delivered. Shingrix is a recombinant zoster vaccine used for the prevention of herpes zoster (shingles) in immunocompromised populations, making this procurement critical for military healthcare system immunization programs.
This delivery order is executed under Cencora's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical, valued at up to $999,999,999.00 through December 2031. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen/Cencora serves as a critical vendor for federal medical procurement across the military healthcare system, supplying an extensive range of pharmaceutical products, medical supplies, vaccines, and specialty medications. The competitive award to this established prime vendor demonstrates the Defense Logistics Agency's reliance on AmerisourceBergen's capability to efficiently fulfill essential medical commodities required by military treatment facilities and related federal healthcare institutions.
Quick answers
Who was awarded contract SPE2DR26F9KS0?
SPE2DR26F9KS0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F9KS0 worth?
The government has obligated $13,313 on SPE2DR26F9KS0.
Is contract SPE2DR26F9KS0 an order under another contract?
Yes. SPE2DR26F9KS0 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9KS0 competed?
The extent of competition for SPE2DR26F9KS0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award